Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Press Release Nov 18 2022

· Issued by Sun Pharmaceutical Industries Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-18-2022-3

Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 18-Nov-2022 titled SEZABY��� phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures

View Attachment

6ix hasn’t read this filing yet.

Sun Pharmaceutical Industries Limited on 6ix

Earlier from Sun Pharmaceutical Industries

Later from Sun Pharmaceutical Industries

All Sun Pharmaceutical Industries news releases